Class information for: |
Basic class information |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
| Cluster id | Level | Cluster label | #P |
|---|---|---|---|
| 10 | 4 | IMMUNOLOGY//TRANSPLANTATION//RHEUMATOLOGY | 1369268 |
| 46 | 3 | VIROLOGY//HIV 1//AIDS RESEARCH AND HUMAN RETROVIRUSES | 102919 |
| 1646 | 2 | ENDOGENOUS RETROVIRUS//HUMAN ENDOGENOUS RETROVIRUS//VIROLOGY | 7198 |
| 33103 | 1 | RT ASSAY//HOST MEDIATED INVIVO INVITRO ASSAY//POLY DNP RNA | 143 |
Terms with highest relevance score |
| rank | Category | termType | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
|---|---|---|---|---|---|---|
| 1 | RT ASSAY | authKW | 918326 | 3% | 83% | 5 |
| 2 | HOST MEDIATED INVIVO INVITRO ASSAY | authKW | 661196 | 2% | 100% | 3 |
| 3 | POLY DNP RNA | authKW | 440797 | 1% | 100% | 2 |
| 4 | REVERSE TRANSCRIPTASE INHIBITING ANTIBODY | authKW | 440797 | 1% | 100% | 2 |
| 5 | TNF ALPHA ELISA | authKW | 440797 | 1% | 100% | 2 |
| 6 | REVERSE TRANSCRIPTASE ASSAY | authKW | 344366 | 3% | 31% | 5 |
| 7 | PRODUCT ENHANCED REVERSE TRANSCRIPTASE ASSAY | authKW | 330595 | 2% | 50% | 3 |
| 8 | 2 3 7 8 TETRACHLORDIBENZO P DIOXIN | authKW | 293863 | 1% | 67% | 2 |
| 9 | 2 FLUOROPOLYNUCLEOLIDES | authKW | 220399 | 1% | 100% | 1 |
| 10 | 5 BROMO 2 DEOXYURIDINE TRIPHOSPHATE | authKW | 220399 | 1% | 100% | 1 |
Web of Science journal categories |
| chi_square_rank | Category | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
|---|---|---|---|---|---|
| 1 | Virology | 1933 | 28% | 0% | 40 |
| 2 | Biochemical Research Methods | 1151 | 30% | 0% | 43 |
| 3 | Biotechnology & Applied Microbiology | 802 | 32% | 0% | 46 |
| 4 | Biochemistry & Molecular Biology | 69 | 22% | 0% | 31 |
| 5 | Immunology | 49 | 10% | 0% | 15 |
| 6 | Oncology | 45 | 11% | 0% | 16 |
| 7 | Chemistry, Analytical | 38 | 8% | 0% | 12 |
| 8 | Pharmacology & Pharmacy | 22 | 10% | 0% | 14 |
| 9 | Microbiology | 19 | 6% | 0% | 9 |
| 10 | Medicine, Research & Experimental | 14 | 5% | 0% | 7 |
Address terms |
| chi_square_rank | term | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
|---|---|---|---|---|---|
| 1 | BIOL PRODUCT CONTROL | 220399 | 1% | 100% | 1 |
| 2 | BLOOD SAFETY CONTRIBUT PROGRAM | 220399 | 1% | 100% | 1 |
| 3 | H LEE MOFFITT CANC CLIN INVEST PRO | 220399 | 1% | 100% | 1 |
| 4 | H LEE MOFFITT CANC HEMATOL MALIGNA | 220399 | 1% | 100% | 1 |
| 5 | INTERNAL MED INTERDISCIPLINARY ONCOL PR | 220399 | 1% | 100% | 1 |
| 6 | QUAL CONTROL DRUG FOOD | 220399 | 1% | 100% | 1 |
| 7 | UNITE CONTROLE MEDICAMENTS IMMUNOL | 220399 | 1% | 100% | 1 |
| 8 | VACCINE POTENCY SECT | 220399 | 1% | 100% | 1 |
| 9 | ANIM CELL BANK | 110198 | 1% | 50% | 1 |
| 10 | ESSENTIAL MED HLTH PROD EMP | 110198 | 1% | 50% | 1 |
Journals |
| chi_square_rank | term | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
|---|---|---|---|---|---|
| 1 | JOURNAL OF VIROLOGICAL METHODS | 12467 | 14% | 0% | 20 |
| 2 | BIOLOGICALS | 9967 | 6% | 1% | 8 |
| 3 | OLIGONUCLEOTIDES | 7368 | 2% | 1% | 3 |
| 4 | WHO TECHNICAL REPORT SERIES | 3057 | 1% | 1% | 2 |
| 5 | BIOTECHNOLOGY AND APPLIED BIOCHEMISTRY | 2541 | 3% | 0% | 5 |
| 6 | ANTISENSE & NUCLEIC ACID DRUG DEVELOPMENT | 2366 | 1% | 1% | 2 |
| 7 | SURVEY OF IMMUNOLOGIC RESEARCH | 1287 | 1% | 1% | 1 |
| 8 | CLINICAL AND DIAGNOSTIC VIROLOGY | 1048 | 1% | 0% | 1 |
| 9 | BIOTECHNIQUES | 898 | 3% | 0% | 5 |
| 10 | ANTICANCER RESEARCH | 716 | 6% | 0% | 8 |
Author Key Words |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Classes with closest relation at Level 1 |